Silencing of PRR11 suppresses cell proliferation and induces autophagy in NSCLC cells
- PMID: 30258945
- PMCID: PMC6150120
- DOI: 10.1016/j.gendis.2017.12.003
Silencing of PRR11 suppresses cell proliferation and induces autophagy in NSCLC cells
Abstract
Our previous studies have demonstrated that proline-rich protein 11 (PRR11) is a novel tumor-related gene and implicates in regulating the proliferation in lung cancer. However, its precise role in cell cycle progression remains unclear. Our recent evidences show that PRR11 silencing has an effect on autophagy in non-small-cell lung cancer (NSCLC) cells. Two human NSCLC cell lines, H1299 and A549 were transiently transfected with against PRR11 siRNA. The Cell Counting Kit-8 and plate clone formation assay showed that downregulation of PRR11 inhibited the cell proliferation associated with cell cycle related genes reduced. And our data suggested that PRR11 depletion expression enhanced the autophagosomes formation, followed with downregulation of P62 and upregulation of LC3-II protein. Furthermore, the immunoblotting results indicated that silencing of PRR11 inactivated the Akt/mTOR signaling pathway. Collectively, these results demonstrated PRR11 had an effective role in autophagy in NSCLC cells through Akt/mTOR autophagy signaling pathways. Therefore, it is helpful to clarify the function of PRR11 in tumorigenesis of NSCLC.
Keywords: Akt/mTOR; Autophagy; Cell Counting Kit-8, (CCK8); Cell proliferation; Non-small-cell lung cancer; PRR11; chromosomal instability, (CIN); lysosome-associated membrane protein 1, (Lamp1); non-small-cell lung cancer, (NSCLC); proline-rich protein 11, (PRR11); small cell lung cancer, (SCLC).
Figures
Similar articles
-
Silencing of NRAGE induces autophagy via AMPK/Ulk1/Atg13 signaling pathway in NSCLC cells.Tumour Biol. 2017 Jun;39(6):1010428317709676. doi: 10.1177/1010428317709676. Tumour Biol. 2017. PMID: 28639909
-
PRR11 is a novel gene implicated in cell cycle progression and lung cancer.Int J Biochem Cell Biol. 2013 Mar;45(3):645-56. doi: 10.1016/j.biocel.2012.12.002. Epub 2012 Dec 12. Int J Biochem Cell Biol. 2013. PMID: 23246489
-
PRR11 regulates late-S to G2/M phase progression and induces premature chromatin condensation (PCC).Biochem Biophys Res Commun. 2015 Mar 13;458(3):501-508. doi: 10.1016/j.bbrc.2015.01.139. Epub 2015 Feb 7. Biochem Biophys Res Commun. 2015. PMID: 25666944
-
Luteoloside induces G0/G1 arrest and pro-death autophagy through the ROS-mediated AKT/mTOR/p70S6K signalling pathway in human non-small cell lung cancer cell lines.Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):263-269. doi: 10.1016/j.bbrc.2017.10.042. Epub 2017 Oct 9. Biochem Biophys Res Commun. 2017. PMID: 29024631
-
PRR11 in Malignancies: Biological Activities and Targeted Therapies.Biomolecules. 2022 Dec 1;12(12):1800. doi: 10.3390/biom12121800. Biomolecules. 2022. PMID: 36551227 Free PMC article. Review.
Cited by
-
PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor.J Neurooncol. 2024 May;168(1):139-149. doi: 10.1007/s11060-024-04655-w. Epub 2024 Apr 25. J Neurooncol. 2024. PMID: 38662151
-
MiR-503-5p functions as an oncogene in oral squamous cell carcinoma by targeting Smad7.Histol Histopathol. 2020 Aug;35(8):893-901. doi: 10.14670/HH-18-220. Epub 2020 Apr 22. Histol Histopathol. 2020. PMID: 32319077
-
A targetable PRR11-DHODH axis drives ferroptosis- and temozolomide-resistance in glioblastoma.Redox Biol. 2024 Jul;73:103220. doi: 10.1016/j.redox.2024.103220. Epub 2024 May 30. Redox Biol. 2024. PMID: 38838551 Free PMC article.
-
Causal network perturbations for instance-specific analysis of single cell and disease samples.Bioinformatics. 2020 Apr 15;36(8):2515-2521. doi: 10.1093/bioinformatics/btz949. Bioinformatics. 2020. PMID: 31873725 Free PMC article.
-
PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma.Sci Rep. 2023 Feb 4;13(1):2051. doi: 10.1038/s41598-023-29316-2. Sci Rep. 2023. PMID: 36739300 Free PMC article.
References
-
- Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA A Cancer J Clin. 2013;63:11–30. - PubMed
-
- Bai H., Mao L., Wang H.S. Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer. J Clin Oncol. 2009;27:2653–2659. - PubMed
-
- Ettinger D.S., Akerley W., Borghaei H. Non-small cell lung cancer, version 2.2013. J Natl Compr Canc Netw. 2013;11:645–653. quiz 653. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
